Literature DB >> 21251193

The expanding menagerie: animal models of hemophilia A.

P E Monahan1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21251193     DOI： 10.1111/j.1538-7836.2010.04053.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  9 in total

1.  A new mouse model for wound healing in hemophilia A.

Authors:  Guangwei Gao; Dhahiri Saidi Mashausi; Hema Negi; Dongsheng Li; Dawei Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.

Authors:  Krithika A Shetty; Matthew P Kosloski; Donald E Mager; Sathy V Balu-Iyer
Journal:  Biopharm Drug Dispos       Date:  2016-09-13       Impact factor: 1.627

Review 3.  Animal models of hemophilia.

Authors:  Denise E Sabatino; Timothy C Nichols; Elizabeth Merricks; Dwight A Bellinger; Roland W Herzog; Paul E Monahan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

4.  Anti-factor IXa/X bispecific antibody ACE910 prevents joint bleeds in a long-term primate model of acquired hemophilia A.

Authors:  Atsushi Muto; Kazutaka Yoshihashi; Minako Takeda; Takehisa Kitazawa; Tetsuhiro Soeda; Tomoyuki Igawa; Zenjiro Sampei; Taichi Kuramochi; Akihisa Sakamoto; Kenta Haraya; Kenji Adachi; Yoshiki Kawabe; Keiji Nogami; Midori Shima; Kunihiro Hattori
Journal:  Blood       Date:  2014-10-01       Impact factor: 22.113

5.  Application of in-vitro-cultured primary hepatocytes to evaluate species translatability and AAV transduction mechanisms of action.

Authors:  Su Liu; Lisa Razon; Olivia Ritchie; Choong-Ryoul Sihn; Britta Handyside; Geoffrey Berguig; Jill Woloszynek; Lening Zhang; Paul Batty; David Lillicrap; Vishal Agrawal; Christa Cortesio; Kahsay Gebretsadik; Hassibullah Akeefe; Peter Colosi; Benjamin Kim; Stuart Bunting; Sylvia Fong
Journal:  Mol Ther Methods Clin Dev       Date:  2022-05-29       Impact factor: 5.849

6.  Soy Phosphatidylinositol-Containing Lipid Nanoparticle Prolongs the Plasma Survival and Hemostatic Efficacy of B-domain-Deleted Recombinant Canine Factor VIII in Hemophilia A Dogs.

Authors:  Krithika A Shetty; Elizabeth P Merricks; Robin Raymer; Natalie Rigsbee; Timothy C Nichols; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2016-06-30       Impact factor: 3.534

7.  In vitro and In vivo Model Systems for Hemophilia A Gene Therapy.

Authors:  Jianhua Mao; Xiaodong Xi; Philipp Kapranov; Biao Dong; Jenni Firrman; Ruian Xu; Weidong Xiao
Journal:  J Genet Syndr Gene Ther       Date:  2013-01-17

8.  A Foundational Study for Normal F8-Containing Mouse Models for the miRNA Regulation of Hemophilia A: Identification and Analysis of Mouse miRNAs that Downregulate the Murine F8 Gene.

Authors:  Katarzyna I Jankowska; Maitreyi Chattopadhyay; Zuben E Sauna; Chintamani D Atreya
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

9.  CRISPR/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs.

Authors:  Jiahuan Chen; Beiying An; Biao Yu; Xiaohuan Peng; Hongming Yuan; Qiangbing Yang; Xue Chen; Tingting Yu; Lingyu Wang; Xinwei Zhang; He Wang; Xiaodong Zou; Daxin Pang; Hongsheng Ouyang; Xiaochun Tang
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.